The Medicines Company announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating loss was USD 61.369 million compared to USD 48.825 million a year ago. Net loss was USD 73.994 million compared to USD 55.634 million a year ago. Basic loss per share from continuing operations was USD 0.92 compared to USD 0.7 a year ago. Basic loss per share was USD 0.92 compared to USD 0.75 a year ago. For the nine months, operating loss was USD 153.363 million compared to USD 165.679 million a year ago. Net loss was USD 193.914 million compared to USD 80.682 million a year ago. Basic loss per share from continuing operations was USD 2.55 compared to USD 2.6 a year ago. Basic loss per share was USD 2.55 compared to USD 1.1 a year ago.